| Scrip code | 544583 |
|---|---|
| NSE Symbol | CANHLIFE |
| MSEI Symbol | NOTLISTED |
| ISIN | INE01TY01017 |
| Name of Company | CANARA HSBC LIFE INSURANCE COMPANY LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Type Of Insurance | Non-Linked Policy And Linked Policy |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 28-04-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 22-04-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Fourth quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Start date and time of board meeting | 28-04-2026 15:45:00 |
| End date and time of board meeting | 28-04-2026 16:40:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Direct |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Whether the company has any related party? | Yes |
| Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? | Yes |
| (I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public | NA |
| (II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. | NA |
| (III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? | No |
| (a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication? | |
| (b) If answer to above question is No, please explain the reason for not complying. | |
| Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? | Yes |
| Latest Date on which RPT policy is updated | 09-02-2026 |
| Indicate Company website link for updated RPT policy of the Company | https://www.canarahsbclife.com/investor-relations/policies-and-code-of-conduct |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | No |
| No. of times funds raised during the quarter | |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| During the Financial 2025-26, the Company has issued unsecured, rated, listed, subordinated, redeemable, fully-paid, non-cumulative, non-convertible debentures (NCDs) in the nature of ‘Subordinated Debt’ in accordance with the IRDAI (Registration, Capital Structure, Transfer of Shares and Amalgamation of Insurers) Regulations, 2024 aggregating to Rs 25,000 lakhs at a coupon rate of 8.15% per annum. The said NCDs were allotted on March 13, 2026, and are redeemable at the end of 10 years from the date of allotment with a call option with the Company to redeem the NCD post the completion of 5 years from the date of allotment and every year thereafter. These NCDs have been rated “CRISIL AA+/Stable” by CRISIL and “CARE AA+/Stable” by CARE. | |
| Partiuclars | Current Quarter | Year to Date Figures | |
|---|---|---|---|
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | |
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | |
| Whether results are audited or unaudited | Audited | Audited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Policyholders' Accounts | |||
| 1 | Income | ||
| (i) | Gross premium income | ||
| (a) | First Year Premium | 67,387.00 | 2,58,480.00 |
| (b) | Renewal Premium | 2,12,679.00 | 6,12,870.00 |
| (c) | Single Premium | 31,358.00 | 1,33,209.00 |
| Gross premium income | 3,11,424.00 | 10,04,559.00 | |
| (ii) | Net premium income | 3,06,066.00 | 9,84,098.00 |
| (iii) | Income from investments (Net) | (1,71,585.00) | 1,60,088.00 |
| (iv) | Other income | ||
| 1 | Other Income | 629.00 | 2,259.00 |
| Total other income | 629.00 | 2,259.00 | |
| (v) | Transfer Of Funds From Shareholders Account | (8,356.00) | 5,040.00 |
| (vi) | Total Income | 1,26,754.00 | 11,51,485.00 |
| 2 | Expenses | ||
| (i) | Commission on | ||
| (a) | First Year Premium | 12,255.00 | 39,667.00 |
| (b) | Renewal Premium | 5,122.00 | 15,207.00 |
| (c) | Single Premium | 2,235.00 | 7,471.00 |
| Total Commission | 19,612.00 | 62,345.00 | |
| (ii) | Net Commission | 19,612.00 | 62,345.00 |
| (iii) | Operating Expenses related to insurance business | ||
| (a) | Employees remuneration and welfare expenses | 23,430.00 | 75,844.00 |
| (b) | Administration expenses | 0.00 | 0.00 |
| (c) | Advertisement and publicity | 0.00 | 0.00 |
| (b) | Other operating expenses | ||
| 1 | Other operating expenses | 14,990.00 | 49,511.00 |
| Total other operating expenses | 14,990.00 | 49,511.00 | |
| Total operating expenses related to insurance business | 38,420.00 | 1,25,355.00 | |
| Total Expenses of Management | 58,032.00 | 1,87,700.00 | |
| (iv) | Provisions for doubtful debts (including bad debts written off) | 0.00 | 0.00 |
| (v) | Provisions for diminution in value of investments | 0.00 | 0.00 |
| (vi) | Goods & Service tax charge on linked charges | (15.00) | 4,095.00 |
| (vii) | Provision for taxes | ||
| Current Tax | 0.00 | 0.00 | |
| Deffered Tax | 0.00 | 0.00 | |
| Total provision of taxes | 0.00 | 0.00 | |
| (viii) | Benefits Paid (Net) | 1,25,599.00 | 4,61,089.00 |
| (ix) | Change in actuarial liability | (47,171.00) | 4,86,682.00 |
| Total Expenses | 1,36,445.00 | 11,39,566.00 | |
| 3 | Net Surplus(Deficit) | (9,691.00) | 11,919.00 |
| 4 | Appropriations | ||
|---|---|---|---|
| (a) | Transferred to Shareholders A/c | (7,078.00) | 8,761.00 |
| (b) | Funds for Future Appropriation | (2,613.00) | 3,158.00 |
| 5 | Details of Surplus / Deficit | ||
| (a) | Interim bonus paid | 749.00 | 2,930.00 |
| (b) | Allocation of bonus to policyholders | 11,831.00 | 11,831.00 |
| (c) | Surplus shown in the Revenue Account | (9,691.00) | 11,919.00 |
| (d) | Terminal bonus paid | 0.00 | 0.00 |
| Total Surplus (Deficit ) | 2,889.00 | 26,680.00 | |
| 1 | Income | ||
|---|---|---|---|
| (i) | Transfer from Poliycholders' Account | (7,078.00) | 8,761.00 |
| (ii) | Income under Shareholders' Account | ||
| (a) | Investment Income | 2,932.00 | 11,407.00 |
| (b) | Other income | ||
| 1 | Other income | 0.00 | 0.00 |
| Total Other income | 0.00 | 0.00 | |
| Total income under shareholders account | 2,932.00 | 11,407.00 | |
| Total Income | (4,146.00) | 20,168.00 | |
| 2 | Expenses | ||
| (i) | Expenses other than those related to insurance business | 367.00 | 1,011.00 |
| (ii) | Transfer of funds to policyholders account | (8,356.00) | 5,040.00 |
| (iii) | Provisions for doubtful debts (including write off) | (18.00) | 39.00 |
| (iv) | Provisions for diminution in value of investments | 0.00 | 0.00 |
| Total Expenses | (8,007.00) | 6,090.00 | |
| 3 | Profit/ (loss) before tax | 3,861.00 | 14,078.00 |
| 4 | Provisions for tax | 388.00 | 1,417.00 |
| (i) | Current tax | 388.00 | 1,417.00 |
| (ii) | Deffered tax | 0.00 | 0.00 |
| 5 | Profit / (loss) after tax and before Extraordinary Items | 3,473.00 | 12,661.00 |
| 6 | Extraordinary Items (Net of tax expenses) | 0.00 | 0.00 |
| 7 | Profit/ (loss) after tax and Extraordinary Items | 3,473.00 | 12,661.00 |
| 8 | Dividend per share | ||
| (a) | Interim Dividend | 0.00 | 0.00 |
| (b) | Final Dividend | 0.40 | 0.40 |
| 9 | Profit/(Loss) carried to Balance Sheet | 53,047.00 | 53,047.00 |
| 10 | Paid up equity share capital | 95,000.00 | |
| 11 | Reserve & Surplus (excluding Revaluation Reserve) | 65,547.00 | 65,547.00 |
| 12 | Fair Value Change Account and Revaluation Reserve (Shareholders) | 0.00 | |
| 13 | Assets | ||
| (i) | Investments: | ||
| (a) | Shareholders | 1,90,101.00 | |
| (b) | Policyholders Fund excluding Linked Assets | 26,44,972.00 | |
| (c) | Assets held to cover Linked Liabilities | 17,76,742.00 | |
| Total Investments | 46,11,815.00 | ||
| (b) | Other Assets (Net of current liabilities and provisions) | 70,629.00 | |
| Total Assets | 46,82,444.00 | ||
| 14 | Analytical Ratios | ||
| (i) | Solvency Ratio | 189.8900 | 189.8900 |
| (ii) | Expenses of Management Ratio | 18.6300 | 18.6800 |
| (iii) | Policyholder 's liabilities to shareholders' fund | 2,800.98 | 2,800.98 |
| (iv) | Earnings per share (Rs.): | ||
| (a) | Basic and diluted EPS before extraordinary items (net of tax expense) for the period (not to be annualized) | 0.37 | 1.33 |
| (b) | Basic and diluted EPS after extraordinary items (net of tax expense) for the period (not to be annualized) | 0.37 | 1.33 |
| (v) | NPA ratios: (for policyholders' fund) | ||
| (a) | Gross NPAs | ||
| Non Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 0.00 | 0.00 | |
| Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 3,237.00 | 3,237.00 | |
| Net NPAs | |||
| Non Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 0.00 | 0.00 | |
| Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 0.00 | 0.00 | |
| % of Gross NPAs | |||
| Non Linked | |||
| Par | 0 | 0 | |
| Non Par | 0 | 0 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | 0.0700 | 0.0700 | |
| % of Net NPAs | |||
| Non Linked | |||
| Par | 0 | 0 | |
| Non Par | 0 | 0 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | 0 | 0 | |
| (vi) | Yield on Investments (on policyholders' fund) | ||
| (a) | Without unrealised gains | ||
| Non Linked | |||
| Par | 1.7200 | 7.9300 | |
| Non Par | 1.8700 | 7.6800 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | 1.5400 | 5.8300 | |
| (b) | With unrealised gains | ||
| Non Linked | |||
| Par | 0.0500 | 6.3100 | |
| Non Par | 1.6600 | 7.4200 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | -11.2800 | -2.7700 | |
| (vii) | NPA ratios: (for shareholders' fund) | ||
| (a) | Gross NPAs | 8,610.00 | 8,610.00 |
| Net NPAs | 0.00 | 0.00 | |
| (b) | Percentage of Gross NPAs | 4.4500 | 4.4500 |
| Percentage of Net NPAs | 0 | 0 | |
| (viii) | Yield on Investments (on shareholders' fund) | ||
| (a) | Without unrealised gains | 1.76 | 7.51 |
| (b) | With unrealised gains | 1.76 | 7.51 |
| (ix) | Persistency Ratio | ||
| 1 | 13th Month | 82.1300 | 86.3500 |
| 2 | 25th Month | 70.0600 | 73.6500 |
| 3 | 37th Month | 62.8200 | 65.3300 |
| 4 | 49th Month | 58.8900 | 60.7200 |
| 5 | 61st Month | 51.100 | 55.3700 |
| (ix) | Other Rations | ||
| (x) | Conservation Ratio | 84.5900 | 86.5700 |
| (xi) | Percentage of shares held by Government of India (in case of public sector insurance companies) | 0 | 0 |
| Investor Compliants | |||
|---|---|---|---|
| (i) | No of investor complaints pending at the beginning of the period | 0 | 0 |
| (ii) | No of investor complaints during the period | 0 | 0 |
| (iii) | No of investor complaints disposed off during the period | 0 | 0 |
| (iv) | No of investor complaints remaining unresolved at the end of the period | 0 | 0 |
| (c) | Notes Format for financial results by life insurance companies filed with stock exchanges |
|---|---|
| 1. Net Premium Income is Net of Reinsurance 2. Income from Investments (Net) - Policyholders' is Net of Amortization and losses (including capital gains). For the quarter ended 31 March 2026 and the year ended 31 March 2026, income is lower compared to the quarter ended 31 December 2025, the quarter ended 31 March 2025, and the year ended 31 March 2025, respectively. This decrease is attributable to the Mark to Market (MTM) impact on investments in equity markets within Unit Linked Funds 3. Transfer of funds from Shareholders' A/c and Transfer of funds to Policyholders' A/c Includes contribution of funds from shareholders accounts towards excess EOM and remuneration of MD/CEOs/WTD/Other KMPs 4. Benefits Paid (Net) is Inclusive of interim and other bonuses and net of reinsurance 5. Expenses other than those related to insurance business is Inclusive of Corporate Social Responsibility expenditure, Interest on Subordinate debt and Penalties (if any) 6. Dividend per share is Interim and Final dividend recommended for respective financial year 7. Advertisement and publicity expenses have been included in other operating expenses for the the current period. 8. Interim Bonus includes Terminal Bonus. 9. Profit carried to Balance Sheet Represents Accumulated Profit 10. Analytical ratios have been calculated as per definition given in IRDAI Analytical ratios disclosure 11. Company has provided 100% provision on CPs and NCDs of IL&FS and IL&FS financial services Ltd, due to default in repayment obligations due to downgrade of rating to Default (D) category. Hence, Net NPA amount would become zero. 12. NPA: Profit/Loss on Derivative amount (TRAD & AnnuityR Fund) is being considered as Unrealised Gain/Loss and is included while computing the Yield with Unrealised Gain and realised 13. Persistency ratio (Regular Premium/ Limited Premium Payment under Individual Category): 13.1 Persistency ratios are calculated in accordance with IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024 and the Master circular issued thereafter. As a result of a change in methodology adopted in the current period, previous year/quarter figures have been changed to ensure consistency and comparability. Persistency ratios include individual business only, Group business policies have been excluded from the persistency calculation. 13.2 Persistency ratios for the quarter ended March 31, 2026 have been calculated on March 31, 2026 for the policies issued in December to February period of the relevant years. For example, the 13th month persistency for the quarter ended March 31, 2026 is calculated for policies issued from December 1, 2024 to February 28, 2025. 13.3 Persistency ratios for the year ended March 31, 2026 have been calculated on March 31, 2026 for the policies issued in March to February period of the relevant years. For example, the 13th month persistency for year ended March 31, 2026 is calculated for policies issued from March 1, 2024 to February 28, 2025. | |
| Partiuclars | Current Quarter | Year to Date Figures | |
|---|---|---|---|
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | |
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | |
| Whether results are audited or unaudited | Audited | Audited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Segment Income | |||
| 1 | Name of segment | Linked Non Participating - Life | |
| (i) | Net premium | 87,838.00 | 3,86,263.00 |
| (ii) | Income form investments | (2,16,847.00) | (23,473.00) |
| (iii) | Transfer of funds from shareholders' account | (5,648.00) | 4,492.00 |
| (iv) | Other income | 65.00 | 357.00 |
| 2 | Name of segment | Linked Non Participating - Pension | |
| (i) | Net premium | 2,254.00 | 4,613.00 |
| (ii) | Income form investments | (1,462.00) | 499.00 |
| (iii) | Transfer of funds from shareholders' account | 107.00 | 107.00 |
| (iv) | Other income | 1.00 | 4.00 |
| 3 | Name of segment | Linked Non Participating - Health | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 4 | Name of segment | Linked Non Participating - Others | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 5 | Name of segment | Non Linked Participating - Life | |
| (i) | Net premium | 48,042.00 | 1,21,821.00 |
| (ii) | Income form investments | 14,287.00 | 60,274.00 |
| (iii) | Transfer of funds from shareholders' account | 60.00 | 121.00 |
| (iv) | Other income | 262.00 | 914.00 |
| 6 | Name of segment | Non Linked Participating - Pension | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 7 | Name of segment | Non Linked Participating - Health | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 8 | Name of segment | Non Linked Participating - Others | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 9 | Name of segment | Non Linked Non Participating - Life | |
| (i) | Net premium | 1,30,969.00 | 3,80,880.00 |
| (ii) | Income form investments | 27,429.00 | 1,03,632.00 |
| (iii) | Transfer of funds from shareholders' account | 140.00 | 264.00 |
| (iv) | Other income | 281.00 | 879.00 |
| 10 | Name of segment | Non Linked Non Participating - Pension | |
| (i) | Net premium | 36,929.00 | 90,361.00 |
| (ii) | Income form investments | 4,999.00 | 19,120.00 |
| (iii) | Transfer of funds from shareholders' account | (3,016.00) | 55.00 |
| (iv) | Other income | 20.00 | 105.00 |
| 11 | Name of segment | Non Linked Non Participating - Health | |
| (i) | Net premium | 34.00 | 160.00 |
| (ii) | Income form investments | 9.00 | 36.00 |
| (iii) | Transfer of funds from shareholders' account | 1.00 | 1.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 12 | Name of segment | Non Linked Non Participating - Others | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 13 | Name of segment | Shareholders | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 2,932.00 | 11,407.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 14 | Name of segment | Unallocated | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| Partiuclars | Current Quarter | Year to Date Figures | |
|---|---|---|---|
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | |
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | |
| Whether results are audited or unaudited | Audited | Audited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Segment Surplus/(Deficit) (net of transfer from shareholders' A/c) | |||
| 1 | Linked Non Participating - Life | 5,702.00 | (4,302.00) |
| 2 | Linked Non Participating - Pension | (170.00) | (106.00) |
| 3 | Linked Non Participating - Health | 0.00 | 0.00 |
| 4 | Linked Non Participating - Others | 0.00 | 0.00 |
| 5 | Non Linked Participating - Life | 1,564.00 | 1,640.00 |
| 6 | Non Linked Participating - Pension | 0.00 | 0.00 |
| 7 | Non Linked Participating - Health | 0.00 | 0.00 |
| 8 | Non Linked Participating - Others | 0.00 | 0.00 |
| 9 | Non Linked Non Participating - Life | (8,643.00) | 7,032.00 |
| 10 | Non Linked Non Participating - Pension | 3,097.00 | 57.00 |
| 11 | Non Linked Non Participating - Health | 8.00 | 32.00 |
| 12 | Non Linked Non Participating - Others | 0.00 | 0.00 |
| 13 | Shareholders | 2,303.00 | 9,725.00 |
| 14 | Unallocated | 0.00 | 0.00 |
| Partiuclars | Current Quarter | |
|---|---|---|
| Date of start of reporting period | 01-01-2026 | |
| Date of end of reporting period | 31-03-2026 | |
| Whether results are audited or unaudited | Audited | |
| Nature of report standalone or consolidated | Standalone | |
| Segment Assets | ||
| 1 | Linked Non Participating - Life | 17,62,008.00 |
| 2 | Linked Non Participating - Pension | 28,564.00 |
| 3 | Linked Non Participating - Health | 0.00 |
| 4 | Linked Non Participating - Others | 0.00 |
| 5 | Non Linked Participating - Life | 8,63,836.00 |
| 6 | Non Linked Participating - Pension | 0.00 |
| 7 | Non Linked Participating - Health | 0.00 |
| 8 | Non Linked Participating - Others | 0.00 |
| 9 | Non Linked Non Participating - Life | 15,41,863.00 |
| 10 | Non Linked Non Participating - Pension | 3,00,030.00 |
| 11 | Non Linked Non Participating - Health | 596.00 |
| 12 | Non Linked Non Participating - Others | 0.00 |
| 13 | Shareholders | 1,85,547.00 |
| 14 | Unallocated | 0.00 |
| Partiuclars | Current Quarter | ||
|---|---|---|---|
| Date of start of reporting period | 01-01-2026 | ||
| Date of end of reporting period | 31-03-2026 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Segment Liabilities | |||
| 1 | Linked Non Participating - Life | 17,62,008.00 | |
| 2 | Linked Non Participating - Pension | 28,564.00 | |
| 3 | Linked Non Participating - Health | 0.00 | |
| 4 | Linked Non Participating - Others | 0.00 | |
| 5 | Non Linked Participating - Life | 8,63,836.00 | |
| 6 | Non Linked Participating - Pension | 0.00 | |
| 7 | Non Linked Participating - Health | 0.00 | |
| 8 | Non Linked Participating - Others | 0.00 | |
| 9 | Non Linked Non Participating - Life | 15,41,863.00 | |
| 10 | Non Linked Non Participating - Pension | 3,00,030.00 | |
| 11 | Non Linked Non Participating - Health | 596.00 | |
| 12 | Non Linked Non Participating - Others | 0.00 | |
| 13 | Shareholders | 1,85,547.00 | |
| 14 | Unallocated | 0.00 | |
| Notes to Segment Liabilities | |||
|---|---|---|---|
| Textual Information | 1. Segment Policy Liabilities include funds for future appropriations. | ||
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| A | Date of start of reporting period | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited |
| D | Nature of report standalone or consolidated | Standalone |
| Statement of cash flows | ||
| Cash flows from used in operating activities | ||
| Classes of cash receipts from operating activities | ||
| Receipts from sales of goods and rendering of services | 0.00 | |
| Receipts from royalties fees, commissions and other revenue | 0.00 | |
| Receipts from contracts held for dealing or trading purpose | 0.00 | |
| Receipts from premiums and claims annuities and other policy benefits | 10,01,954.00 | |
| Receipts from rents and subsequent sales of assets held for rental to others and subsequently held for sale | 0.00 | |
| Other cash receipts from operating activities | 1,183.00 | |
| Classes of cash payments from operating activities | ||
| Payments to suppliers for goods and services | 0.00 | |
| Payments from contracts held for dealing or trading purpose | 0.00 | |
| Payments to and on behalf of employees | 0.00 | |
| Payments for premiums and claims, annuities and other policy benefits | 4,69,417.00 | |
| Payments to manufacture or acquire assets held for rental to others and subsequently held for sale | 0.00 | |
| Other cash payments from operating activities | 1,78,908.00 | |
| Net cash flows from (used in) operations | 3,54,812.00 | |
| Dividends received | 0.00 | |
| Interest paid | 0.00 | |
| Interest received | 0.00 | |
| Income taxes paid (refund) | 1,462.00 | |
| Other inflows (outflows) of cash | 0.00 | |
| Net cash flows from (used in) operating activities | 3,53,350.00 | |
| Cash flows from used in investing activities | ||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |
| Other cash receipts from sales of interests in joint ventures | 0.00 | |
| Other cash payments to acquire interests in joint ventures | 0.00 | |
| Proceeds from sales of property, plant and equipment | 34.00 | |
| Purchase of property, plant and equipment | 1,037.00 | |
| Proceeds from sales of investment property | 0.00 | |
| Purchase of investment property | 0.00 | |
| Proceeds from sales of goodwill | 0.00 | |
| Purchase of goodwill | 0.00 | |
| Proceeds from sales of intangible assets | 0.00 | |
| Purchase of intangible assets | 0.00 | |
| Proceeds from biological assets other than bearer plants | 0.00 | |
| Purchase of biological assets other than bearer plants | 0.00 | |
| Proceeds from sales of other long-term assets | 0.00 | |
| Purchase of other long-term assets | 0.00 | |
| Cash advances and loans made to other parties | 0.00 | |
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |
| Dividends received | 0.00 | |
| Interest received | 2,06,671.00 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | (5,72,259.00) | |
| Proceeds from government grants | 0.00 | |
| Net cash flows from (used in) investing activities | (3,66,591.00) | |
| Cash flows from used in financing activities | ||
| Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control | 0.00 | |
| Payments from changes in ownership interests in subsidiaries that do not result in loss of control | 0.00 | |
| Proceeds from issuing shares | 0.00 | |
| Proceeds from issuing other equity instruments | 0.00 | |
| Payments to acquire or redeem entity's shares | 0.00 | |
| Payments of other equity instruments | 0.00 | |
| Proceeds from exercise of stock options | 0.00 | |
| Proceeds from issuing debentures notes bonds etc | 0.00 | |
| Proceeds from borrowings | 25,000.00 | |
| Repayments of borrowings | 0.00 | |
| Payments of lease liabilities | 0.00 | |
| Dividends paid | 3,800.00 | |
| Interest paid | 0.00 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | 0.00 | |
| Net cash flows from (used in) financing activities | 21,200.00 | |
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 7,959.00 | |
| Effect of exchange rate changes on cash and cash equivalents | ||
| Effect of exchange rate changes on cash and cash equivalents /th> | 0.00 | |
| Net increase (decrease) in cash and cash equivalents | 7,959.00 | |
| Cash and cash equivalents cash flow statement at beginning of period | 1,87,154.00 | |
| Cash and cash equivalents cash flow statement at end of period | 1,95,113.00 | |
| Partiuclars | Year ended (dd-mm-yyyy) | ||
|---|---|---|---|
| Date of start of reporting period | 01-04-2025 | ||
| Date of end of reporting period | 31-03-2026 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Sources of Funds | |||
| 1 | Share capital | 95,000.00 | |
| 2 | Reserves and surplus | 65,547.00 | |
| 3 | Share application money received pending allotment of shares | 0.00 | |
| 4 | Credit (Debit) Fair value change account | 0.00 | |
| Sub total | 1,60,547.00 | ||
| 5 | Borrowings | 25,000.00 | |
| 6 | Policyholders' funds | ||
| Credit (Debit) Fair value change account | (13,258.00) | ||
| Policy Liabilities | 26,61,445.00 | ||
| Insurance Reserve | 0.00 | ||
| Revaluation reserve - Investment property | 0.00 | ||
| Linked Liabilities | |||
| Provision for Linked Liabilities | 14,89,296.00 | ||
| Change in fairvalue account | 1,69,579.00 | ||
| Funds for Discontinued Policies | |||
| (i) Discontinued on account of non-payment of premium | 1,15,075.00 | ||
| (ii) Credit (Debit) Fair value change account | 0.00 | ||
| (iii) Others discontinuance | 2,792.00 | ||
| Total Linked Liabilities | 17,76,742.00 | ||
| Sub total | 44,24,929.00 | ||
| 7 | Funds for Future Appropriations | 71,968.00 | |
| Total Sources of Funds | 46,82,444.00 | ||
| APPLICATION OF FUNDS | |||
| 1 | Investments shareholders | 1,90,101.00 | |
| 2 | Investments policyholders | 26,44,972.00 | |
| 3 | Assets Held to cover link Liabilities | 17,76,742.00 | |
| 4 | Loans | 22,044.00 | |
| 5 | Fixed assets | 3,728.00 | |
| 6 | Deferred Tax Asset | 0.00 | |
| 7 | Current assets | ||
| Cash and bank balances | 61,333.00 | ||
| Advances and other assets | 1,06,747.00 | ||
| Sub-total (a) | 1,68,080.00 | ||
| 8 | Current liabilities | 1,19,652.00 | |
| 9 | Provisions | 3,571.00 | |
| Sub-total (b) | 1,23,223.00 | ||
| 10 | Net current assets (c) = (a—b) | 44,857.00 | |
| 11 | Miscellaneous expenditure (to the extent not written off or adjusted) | 0.00 | |
| 12 | Debit balance in profit & loss account (shareholders account) | 0.00 | |
| Total | 46,82,444.00 | ||
| 14 | Contigent Liabilities | 34,295.00 | |
| 15 | Notes to the Balance Sheet |
|---|---|
| 1. The Company does not have any subsidiaries/ associates/ joint venture companies, therefore, consolidated financial statements are not applicable to the Company. 2. The above financial results have been prepared in accordance with the relevant provision prescribed by IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024, requirements of Regulation 33 and Regulation 52 read with Regulation 63(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time, to the extent applicable and IRDAI circular IRDA/F&I/REG/CIR/208/10/2016 dated October 25, 2016 on publication of financial results for life insurance companies. 3. The financial results of the Company for the quarter and year ended March 31, 2026 were reviewed by the Audit Committee and subsequently approved by the Board of Directors at its meeting held on April 28, 2026. 4. The above financial results have been Audited by the joint Statutory Auditors of the Company, Raj Har Gopal & Co. (Firm Registration No. 002074N) and Brahmayya & Co. (Firm Registration No. 000513S). 5. The figures for the quarter ended March 31, 2026 and the corresponding quarter ended in the previous year as reported in these financial results are the balancing figures between Audited figures in respect of full financial year and published year-to-date figures upto the end of the third quarter of the relevant financial year. 6. In view of seasonality of industry, the results of interim period are not necessarily indicative of the results that may be expected of any other interim periods or for the full year. 7. As on 31st March 2026, the Company has 950,000,000 Issued, subscribed and paid-up equity shares (face value of Rs 10 each). Pursuant to listing of the Company’s equity shares on stock exchanges in India (NSE and BSE) on October 17, 2025, the existing shareholders sold 237,500,000 equity shares through an offer for sales in its initial public offering (IPO). In this offering, Canara Bank sold 137,750,000 shares and as a result the Company ceases to be a subsidiary of Canara Bank. HSBC Insurance (Asia-Pacific) Holdings Limited and Punjab National Bank also sold 4,750,000 and 95,000,000 shares, respectively. As a result of this transaction, there is no impact on financial position of the Company on the date of adoption of financial statements except as stated above. 8. Pursuant to the notification issued by the Ministry of Labour and Employment, the Code on Wages, 2019, the Code on Social Security, 2020, the Industrial Relations Code, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as the “New Labour Codes”) became effective from November 21, 2025. Accordingly, the Company has recognized incremental estimated obligation on account of the employees past services and based on actuarial valuation, in accordance with Accounting Standard 15 “Employee Benefits” (“AS 15”), the incremental estimates amount to Rs 1,195 lakhs. This additional amount is charged to the Policyholders’ Revenue Account for the year ended March 31, 2026. The Company continues to monitor developments relating to the implementation of the New Labour Codes and will review its estimates and assumptions on an ongoing basis. 9. The Company has instituted an Employee Stock Option Plan namely “Canara HSBC Life Insurance Company Limited - Employee Stock Option Plan 2025” (the “ESOP Scheme”) pursuant to approvals of the Board of Directors and shareholders. The ESOP scheme is administered through a Trust constituted solely for the purpose of implementation and administration of the ESOP Scheme. Under the ESOP scheme, eligible employees are granted stock options that vest over specified periods subject to vesting conditions and are exercisable at a predetermined exercise price within the prescribed exercise period. The scheme is equity-settled in nature. The ESOP Trust has been funded by the Company through interest-free loan for the purpose of acquiring equity shares of the Company from the secondary market. The Trust has not subscribed to or been allotted any fresh equity shares by the Company. The Company accounts for the ESOP Scheme in accordance with the Guidance Note on “Accounting for Share-based Payments” issued by the Institute of Chartered Accountants of India and has adopted the intrinsic value method for measurement of stock options. As at the reporting date, no options have vested and the intrinsic value of options granted is nil; accordingly, no employee compensation expense has been recognized in the Revenue Account or Profit and loss account for the period. The amount advanced by the Company to the ESOP Trust is presented in the balance sheet as “Loan to ESOP Trust” and represents loans/advances recoverable from the Trust, primarily out of the exercise price received from employees upon exercise of vested options, and includes inter alia, the cost of equity shares acquired from the secondary market (including transaction costs), margins placed with brokers, unutilized bank balances and other incidental costs attributable to the administration of the ESOP Scheme. 10. During the Financial 2025-26, the Company has issued unsecured, rated, listed, subordinated, redeemable, fully-paid, non-cumulative, non-convertible debentures (NCDs) in the nature of ‘Subordinated Debt’ in accordance with the IRDAI (Registration, Capital Structure, Transfer of Shares and Amalgamation of Insurers) Regulations, 2024 aggregating to Rs 25,000 lakhs at a coupon rate of 8.15% per annum. The said NCDs were allotted on March 13, 2026, and are redeemable at the end of 10 years from the date of allotment with a call option with the Company to redeem the NCD post the completion of 5 years from the date of allotment and every year thereafter. These NCDs have been rated “CRISIL AA+/Stable” by CRISIL and “CARE AA+/Stable” by CARE. 11. The Board of Directors have recommended a final dividend of Rs 0.40 per equity share of face value of Rs 10 each in its meeting held on April 28, 2026, subject to Shareholders’ approval in their Annual General Meeting. 12. In accordance with the requirements of IRDAI circular on 'Public Disclosures by Insurers' dated September 30, 2021, the Company will publish the financials on the Company's website not later than May 27, 2026. 13. Figures of the previous period have been re-grouped wherever necessary, to conform to the current year presentation. Cash Flow Notes: 1. Payments for premiums and claims, annuities and other policy benefits includes Payments to the re-insurers, net of commissions and claims, Payments to co-insurers, net of claims recovery and Payments of claims. 2. Other cash payments from operating activities includes Payments of commission and brokerage, Payments of other operating expenses (Includes amount paid towards Corporate Social Responsibility expenditure), Preliminary and pre-operative expenses, Deposits, advances and staff loans and Goods and Service Tax (GST) paid. 3. Other inflows (outflows) of cash in Cash flows from used in investing activities includes Purchase of Investments, Loans against policies, Loan Disbursed (Loan to ESOP Trust), Sale of Investments and Investments in money market instruments and in liquid mutual funds (Net) (includes movement in net current assets). 4. Interest received includes Interests and Dividends received. Related Party Transaction Notes: 1. Post merger of Karnataka Vikas Grameena Bank and Karnataka Gramin Bank w.e.f. from 1st May 2025, the merged entity has been renamed as Karnataka Grameena Bank. Hence, we have disclosed all the transactions during the period under Karnataka Grameena Bank. 2. The Company has entered into Forward Rate Agreement (Fixed Income Derivative instruments) with The Hongkong and Shanghai Banking Corporation Limited towards which the outstanding notional principal as on 31st March 2026 is Rs 11,157 Lakhs (As on 31st March 2025 – Rs. NIL) and Margin Receivable on the same as on 31st March 2026 is Rs 1,119 Lakhs (As on 31st March 2025 – Rs. NIL). The Company has also earned an interest income of Rs 21 Lakhs on these margins half year ended 31st March 2026 ( PY – NIL). 3. During the Financial year 2025-26, the Company’s Equity Shares were listed on NSE and BSE, pursuant to an Initial Public Offer (IPO) comprising of 237,500,000 Equity shares of face value of ` 10 each at a price of ` 106 per equity share, offered through an Offer of Sale by its shareholders, as mentioned below: 137,750,000 Equity shares of face value of Rs. 10 each aggregating to Rs. 145,860 Lakhs (with 15,50,000 equity shares offered to eligible employees at Rs. 96.00) by Canara bank, 4,750,000 Equity shares of face value of Rs. 10 each aggregating to Rs. 5,035 Lakhs by HSBC Insurance (Asia-Pacific) Holdings Limited and 95,000,000 Equity Shares of face value of Rs.10 each aggregating to Rs. 100,700 Lakhs by Punjab National Bank. The Company received total proceeds of Rs. 251,595 Lakhs, from the offer for sale on behalf of the selling shareholders, out of which: an amount of Rs. 6,782 Lakhs was retained towards recovery of estimated IPO related expenses, Securities Transaction tax (STT) was paid amounting to Rs. 503 Lakhs, Withholding Tax was paid amounting to Rs. 204 Lakhs and balance amount of Rs. 244,106 Lakhs was remitted to the selling shareholders and hence, the said amount have not been disclosed as a related party transaction under the related party disclosures. Out of the Rs. 6,782 Lakhs retained, the Company has recovered Rs. 6,025 Lakhs, towards IPO related expenses incurred by it, from the selling shareholders, which has been disclosed as related party transactions under the related party disclosures. The remaining balance of Rs. 757 Lakhs in the IPO bank account as at 31st March 2026, is to be utilized towards settlement of remaining IPO related expenses and the balance amount, if any, shall be remitted to the Shareholders. Hence, the same has not been disclosed as a related party transaction under the related party disclosures. Since these expense are borne by shareholders therefore omnibus approval was not taken. * The Company may also from time to time receive interest from investments issued by these related parties, in line with the terms of investments so made. | |
| Whether results are audited or unaudited | Audited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | Brahmayya & Co. | Yes | 29-02-2028 | ||
|---|---|---|---|---|---|
| 2 | Raj Har Gopal & Co. | Yes | 28-02-2029 | ||
Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter) |
| Sr No. | Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken. | ||||||||||||||||||||||||
| Details of the party (listed entity /subsidiary) entering into the transaction | Details of the counterparty | Type of related party transaction | Details of other related party transaction | Value of the related party transaction as approved by the audit committee | Remarks on approval by audit committee | Value of the related party transaction ratified by the audit committee | Date of Audit Committee Meeting where the ratification was approved | Value of transaction during the reporting period | In case monies are due to either party as a result of the transaction | In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments | Details of the loans, inter-corporate deposits, advances or investments | Notes | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | PAN | Name | PAN | Relationship of the counterparty with the listed entity or its subsidiary | Opening balance | Closing balance | Nature of indebtedness (loan/ issuance of debt/ any other etc.) | Details of other indebtedness | Cost | Tenure | Nature (loan/ advance/ intercorporate deposit/ investment ) | Interest Rate (%) | Tenure | Secured/ unsecured | Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) | ||||||||||
| 1 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Premium Income | 1,35,000.00 | - | 32,489.19 | 0.00 | 0.00 | |||||||||||||||
| 2 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Benefits Paid | 50,000.00 | - | 1,545.78 | 0.00 | 0.00 | |||||||||||||||
| 3 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Commission | 60,000.00 | - | 28,641.50 | 589.56 | 1,661.34 | |||||||||||||||
| 4 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Rent | 500.00 | - | 115.45 | 0.00 | 0.00 | |||||||||||||||
| 5 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Reimbursement of expenses- Electricity Charges and Property Tax | 200.00 | - | 2.81 | 0.00 | 0.00 | |||||||||||||||
| 6 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Recovery of IPO related expenses (Note 3) | - | 3,493.00 | 0.00 | 0.00 | ||||||||||||||||
| 7 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Bank Charges | 300.00 | - | 29.85 | 0.00 | 0.00 | |||||||||||||||
| 8 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Premium Income | 20,000.00 | - | 857.56 | 0.00 | 0.00 | |||||||||||||||
| 9 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Commission | 7,500.00 | - | 2,824.45 | 485.27 | 709.77 | |||||||||||||||
| 10 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Bank Charges | 100.00 | - | 12.11 | 0.00 | 0.00 | |||||||||||||||
| 11 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Purchase of Investment - Deposits, Debt & Money market instruments* | 20,000.00 | - | 5,711.62 | 0.00 | 0.00 | |||||||||||||||
| 12 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Margin Receivable (Note 2) | 1,00,000.00 | - | 0.00 | 776.00 | 1,119.00 | |||||||||||||||
| 13 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Interest and Investment Income (Note 2) | 1,00,000.00 | - | 21.11 | 0.00 | 0.00 | |||||||||||||||
| 14 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Guarantees and Collaterals | 2,500.00 | - | 0.00 | 50.00 | 50.00 | |||||||||||||||
| 15 | Canara HSBC Life Insurance Company Limited | HSBC Insurance (Asia-Pacific) Holdings Limited | Promoter | Any other transaction | Recovery of IPO related expenses (Note 3) | - | 120.58 | 0.00 | 0.00 | ||||||||||||||||
| 16 | Canara HSBC Life Insurance Company Limited | Punjab National Bank | Having more than 10 % shareholding as per LODR | Any other transaction | Commission | 1,500.00 | - | 974.07 | 97.57 | 218.60 | |||||||||||||||
| 17 | Canara HSBC Life Insurance Company Limited | Punjab National Bank | Having more than 10 % shareholding as per LODR | Any other transaction | Bank Charges | 50.00 | - | 2.84 | 0.00 | 0.00 | |||||||||||||||
| 18 | Canara HSBC Life Insurance Company Limited | Punjab National bank | Having more than 10 % shareholding as per LODR | Any other transaction | Recovery of IPO related expenses (Note 3) | - | 2,411.52 | 0.00 | 0.00 | ||||||||||||||||
| 19 | Canara HSBC Life Insurance Company Limited | Canara Bank Securities Limited | Promoter Group | Any other transaction | Brokerage | 200.00 | - | 64.12 | 1.14 | 1.43 | |||||||||||||||
| 20 | Canara HSBC Life Insurance Company Limited | Canara Robeco Asset Management Company Limited | Promoter Group | Any other transaction | Sale / Maturity of Investment - Deposits, Debt & Money market instruments* | 10,000.00 | - | 2,076.78 | 0.00 | 0.00 | |||||||||||||||
| 21 | Canara HSBC Life Insurance Company Limited | Karnataka Grameena Bank (Note 1) | Promoter Group | Any other transaction | Premium Income | 12,500.00 | - | 826.93 | 0.00 | 0.00 | |||||||||||||||
| 22 | Canara HSBC Life Insurance Company Limited | Karnataka Grameena Bank (Note 1) | Promoter Group | Any other transaction | Commission | 5,000.00 | - | 2,107.53 | 241.53 | 727.12 | |||||||||||||||
| 23 | Canara HSBC Life Insurance Company Limited | Kerala Grameena Bank | Promoter Group | Any other transaction | Premium Income | 2,500.00 | - | 63.19 | 0.00 | 0.00 | |||||||||||||||
| 24 | Canara HSBC Life Insurance Company Limited | Kerala Grameena Bank | Promoter Group | Any other transaction | Commission | 1,000.00 | - | 170.61 | 27.77 | 87.44 | |||||||||||||||
| 25 | Canara HSBC Life Insurance Company Limited | Can Fin Homes Limited | Promoter Group | Any other transaction | Premium Income | 10,000.00 | - | 5,553.33 | 0.00 | 0.00 | |||||||||||||||
| 26 | Canara HSBC Life Insurance Company Limited | Can Fin Homes Limited | Promoter Group | Any other transaction | Commission | 1,000.00 | - | 281.35 | 33.62 | 79.47 | |||||||||||||||
| 27 | Canara HSBC Life Insurance Company Limited | Canara HSBC Life Insurance Company Limited Group Gratuity Trust | Gratuity Trust | Any other transaction | Premium Income | 2,500.00 | - | 691.00 | 0.00 | 0.00 | |||||||||||||||
| 28 | Canara HSBC Life Insurance Company Limited | Canara HSBC Life Insurance Company Limited Group Gratuity Trust | Gratuity Trust | Any other transaction | Benefits Paid | 2,500.00 | - | 452.02 | 0.00 | 0.00 | |||||||||||||||
| 29 | Canara HSBC Life Insurance Company Limited | Canara HSBC Life Insurance Company Limited Group Gratuity Trust | Gratuity Trust | Any other transaction | Contribution towards Gratuity Plan | 2,500.00 | - | 691.00 | 0.00 | 0.00 | |||||||||||||||
| Total value of transaction during the reporting period | 92,231.30 | ||||||||||||||||||||||||